International Business News - AZN http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Shares of large pharmaceutical companies lacked direction in early Friday trading. The broader market slipped as investors digested new record highs for oil and a surprising jump in new home construction. http://www.ibtimes.com/articles/20080516/opening-glance-pharmaceuticals.htm Fri, 16 May 2008 09:54:34 EDT The global market for cancer drugs will grow twice as fast as that for all other pharmaceuticals as the developing world spends more on health care, a new report says. http://www.ibtimes.com/articles/20080515/global-market-expected-to-drive-cancer-drug-growth.htm Thu, 15 May 2008 02:04:54 EDT AstraZeneca PLC said Wednesday that U.S. regulators have approved its anti-psychotic drug Seroquel as a maintenance treatment for patients with a type of bipolar disorder. http://www.ibtimes.com/articles/20080514/astrazenecas-seroquel-gets-fda-approval.htm Wed, 14 May 2008 07:15:51 EDT Drug developer Pozen Inc. on Thursday raised its outlook for 2008 revenue to between $62 million and $68 million, well above Wall Street estimates. Analysts polled by Thomson Financial expect 2008 revenue of $52.2 million. http://www.ibtimes.com/articles/20080508/pozen-projects-full-year-revenue-above-wall-street-estimates.htm Thu, 08 May 2008 10:41:06 EDT Drug developer Pozen Inc. said Thursday that its first-quarter loss more than tripled on higher operating expenses, though the loss was in-line with Wall Street estimates. http://www.ibtimes.com/articles/20080508/pozen-1q-loss-more-than-triples-on-higher-operating-expenses.htm Thu, 08 May 2008 10:25:26 EDT Shares of OSI Pharmaceuticals rose Wednesday, a day after the biotechnology company beat Wall Street expectations on higher sales of its cancer drug Tarceva. http://www.ibtimes.com/articles/20080507/osi-shares-rise-after-posting-1q-profit-on-cancer-drug-sales.htm Wed, 07 May 2008 16:56:27 EDT AstraZeneca PLC said Tuesday that a European patent has been revoked covering the use of its Symbicort medicine as a treatment for a condition commonly known as "smoker's cough." http://www.ibtimes.com/articles/20080506/astras-symbicort-patent-revoked.htm Tue, 06 May 2008 11:06:18 EDT A Goldman Sachs analyst said Monday he expects Teva Pharmaceutical to update investors on its pending patent challenges when the Israeli generic drugmaker reports first-quarter earnings on Tuesday. http://www.ibtimes.com/articles/20080505/sector-snap-goldman-looking-for-teva-patent-suit-updates.htm Mon, 05 May 2008 11:46:24 EDT AstraZeneca PLC said Wednesday it has applied to U.S. regulators for approval to use its Symbicort asthma drug to treat a condition commonly known as smoker's cough, which would strengthen its competition with rival drugmaker GlaxoSmithKline PLC. http://www.ibtimes.com/articles/20080430/astrazeneca-seeks-us-symbicort-approval.htm Wed, 30 Apr 2008 06:22:49 EDT Among the earnings stories for Thursday, April 24, from AP Financial News: Top stories: http://www.ibtimes.com/articles/20080424/earnings-roundup-ford-electronic-data-systems.htm Thu, 24 Apr 2008 11:11:50 EDT Major drug companies saw their bottom lines buoyed by a weak dollar, one-time gains and other temporary items, but their shares still fell because of basic economic problems hurting the industry. http://www.ibtimes.com/articles/20080421/analysts-drug-maker-earns-get-temporary-lift-amid-problems.htm Mon, 21 Apr 2008 19:13:04 EDT Drug developer Mylan Inc. said Monday it received Food and Drug Administration approval for generic versions of AstraZeneca's hypertension treament, Plendil extended-release tablets. http://www.ibtimes.com/articles/20080421/mylan-gets-fda-approval-for-generic-hypertension-drug.htm Mon, 21 Apr 2008 15:07:10 EDT The drugmaker Merck & Co. says its profit almost doubled in the first quarter due to a $1.4 billion distribution from a partner drug company. It sales were slightly higher. http://www.ibtimes.com/articles/20080421/merck-profit-almost-doubles-in-1q-on-gain-sales-edge-up.htm Mon, 21 Apr 2008 08:08:05 EDT U.S.-traded shares of British drug makers GlaxoSmithKline PLC and AstraZeneca PLC rose with the broader market Friday, but an analyst downgraded the stocks, saying profit and sales will slip over the... http://www.ibtimes.com/articles/20080418/adrs-in-focus-european-pharmaceutical-stocks-rise.htm Fri, 18 Apr 2008 16:26:44 EDT Shares of large pharmaceutical companies edged down Tuesday despite positive news, as AstraZeneca PLC settled a long-standing patent dispute over its heartburn drug Nexium and Johnson & Johnson toppe... http://www.ibtimes.com/articles/20080415/closing-glance-pharmaceutical-edge-down-after-j-j-results.htm Tue, 15 Apr 2008 16:53:13 EDT U.S.-traded shares of AstraZeneca and Elan Corp. rose Tuesday on a mixed day for European drug makers. Elan shares got a lift after the Irish company said about 26,000 patients were using its drug T... http://www.ibtimes.com/articles/20080415/adrs-in-focus-elan-and-astrazeneca-lead-european-pharma.htm Tue, 15 Apr 2008 16:25:11 EDT Pfizer Inc. reports earnings for the first quarter on Thursday. The following is a summary of key developments and analyst opinion related to the period. OVERVIEW: Pfizer entered the first quarter w... http://www.ibtimes.com/articles/20080415/earnings-preview-pfizer-poised-to-meet-profit-forecast.htm Tue, 15 Apr 2008 14:47:23 EDT Buyouts drove shares higher in the premarket, with the impending combination of Delta Air Lines Inc. and Northwest Airlines Corp. boosting the airlines sector, bearing out a Lehman Brothers analyst'... http://www.ibtimes.com/articles/20080415/premarket-movers-delta-blockbuster-up.htm Tue, 15 Apr 2008 09:07:56 EDT Shares in pharmaceutical company AstraZeneca PLC soared Tuesday on news that an agreement with an Indian company will delay the release of a generic competitor to its best selling heartburn drug for ... http://www.ibtimes.com/articles/20080415/astrazeneca-settles-ranbaxy-lawsuit.htm Tue, 15 Apr 2008 07:50:10 EDT Sen. Charles Grassley, R-Iowa, recently wrote to 15 drug and medical device makers, asking them to disclose how much money they spend on medical education programs for health care providers. A summar... http://www.ibtimes.com/articles/20080411/drug-companies-may-reveal-donations.htm Fri, 11 Apr 2008 04:11:14 EDT